Microbiota-triggered colonic delivery: Robustness of the polysaccharide approach in the fed state in man

References

• AW Basit. (2005). Advances in colonic drug delivery. Drugs 65 (14):1991–2007.
   PubMed Web of Science ®Google Scholar
• AW Basit, JM Newton, MD Short, WA Waddington, PJ Ell, and LF Lacey. (2001). The effect of polyethylene glycol 400 on gastrointestinal transit: Implications for the formulation of poorly-water soluble drugs. Pharm Res 18 (8):1146–1150.
   PubMed Web of Science ®Google Scholar
• AW Basit, JM Newton, and LF Lacey. (2002). Susceptibility of the H-2-receptor antagonists cimetidine, famotidine and nizatidine, to metabolism by the gastrointestinal microflora. Int J Pharm 237 (1–2):23–33.
   PubMedGoogle Scholar
• AW Basit, F Podczeck, J Michael Newton, WA Waddington, PJ Ell, and LF Lacey. (2004). The use of formulation technology to assess regional gastrointestinal drug absorption in humans. Eur J Pharm Sci 21 (2–3):179–189.
   PubMed Web of Science ®Google Scholar
• S Berggren, C Gall, N Wollnitz, M Ekelund, U Karlbom, J Hoogstraate, D Schrenk, and H Lennernas. (2007). Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine. Mol Pharm 4 (2):252–257.
   PubMedGoogle Scholar
• H Bernhardt, and M Knoke. (1997). Mycological aspects of gastrointestinal microflora. Scand J Gastroenterol 32:102–106.
   PubMed Web of Science ®Google Scholar
• I Bieche, C Narjoz, T Asselah, S Vacher, P Marcellin, R Lidereau, P Beaune, and I de Waziers. (2007). Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genomics 17 (9):731–742.
   PubMed Web of Science ®Google Scholar
• T Bozkurt, G Adler, I Koop, and R Arnold. (1988). Effect of atropine on intestinal phase of pancreatic-secretion in man. Digestion 41 (2):108–115.
   PubMed Web of Science ®Google Scholar
• JM Braganza, K Herman, P Hine, G Kay, and GI Sandle. (1978). Pancreatic-enzymes in human duodenal juice—comparison of responses in secretin pancreozymin and Lundh Borgstrom tests. Gut 19 (5):358–366.
   PubMed Web of Science ®Google Scholar
• JH Cummings, ER Beatty, SM Kingman, SA Bingham, and HN Englyst. (1996). Digestion and physiological properties of resistant starch in the human large bowel. Br J Nutr 75 (5):733–747.
   PubMed Web of Science ®Google Scholar
• L Czako, F Hajnal, J Nemeth, T Takacs, and JH Lonovics. (1999). Effect of a liquid meal given as a bolus into the jejunum on human pancreatic secretion. Pancreas 18 (2):197–202.
   PubMed Web of Science ®Google Scholar
• PB Eckburg, EM Bik, CN Bernstein, E Purdom, L Dethlefsen, M Sargent, SR Gill, KE Nelson, and DA Relman. (2005). Diversity of the human intestinal microbial flora. Science 308 (5728):1635–1638.
   PubMed Web of Science ®Google Scholar
• HN Englyst, and JH Cummings. (1985). Digestion of the polysaccharides of some cereal foods in the human small intestine. Am J Clin Nutr 42 (5):778–787.
   PubMed Web of Science ®Google Scholar
• HN Englyst, and JH Cummings. (1986). Digestion of the carbohydrates of banana (Musa paradisiaca sapientum) in the human small intestine. Am J Clin Nutr 44 (1):42–50.
   PubMed Web of Science ®Google Scholar
• HN Englyst, and JH Cummings. (1987). Digestion of polysaccharides of potato in the small intestine of man. Am J Clin Nutr 45 (2):423–431.
   PubMed Web of Science ®Google Scholar
• HN Englyst, and GJ Hudson. (1996). The classification and measurement of dietary carbohydrates. Food Chem 57 (1):15–21.
   Web of Science ®Google Scholar
• H Englyst, HS Wiggins, and JH Cummings. (1982). Determination of the non-starch polysaccharides in plant foods by gas–liquid chromatography of constituent sugars as alditol acetates. Analyst 107 (1272):307–318.
   PubMed Web of Science ®Google Scholar
• HN Englyst, SM Kingman, GJ Hudson, and JH Cummings. (1996). Measurement of resistant starch in vitro and in vivo. Br J Nutr 75 (5):749–755.
   PubMed Web of Science ®Google Scholar
• P Hildebrand, C Beglinger, K Gyr, JBMJ Jansen, LC Rovati, M Zuercher, CBHW Lamers, I Setnikar, and GA Stalder. (1990). Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man. J Clin Invest 85 (3):640–646.
   PubMed Web of Science ®Google Scholar
• G Holtmann, DG Kelly, and EP DiMagno. (1996). Nutrients and cyclical interdigestive pancreatic enzyme secretion in humans. Gut 38 (6):920–924.
   PubMed Web of Science ®Google Scholar
• VC Ibekwe, HM Fadda, EL McConnell, MK Khela, DF Evans, and AW Basit. (2008a). Interplay between intestinal pH, transit time and feed status on in vivo performance of pH responsive ileo-colonic release systems. Pharm Res 25 ((8)):1828–1835.
   PubMed Web of Science ®Google Scholar
• VC Ibekwe, MK Khela, DF Evans, and AW Basit. (2008b). A new concept in colonic targeting: a combined pH-responsive and bacterial triggered drug delivery technology. 28 ((7)):911–916.
   Google Scholar
• M Katschinski, C Dippel, M Reinshagen, J Schirra, R Arnold, R Nustede, C Beglinger, and G Adler. (1992). Induction of the fed pattern of human exocrine pancreatic-secretion by nutrients—role of cholecystokinin and neurotensin. Clin Investig 70 (10):902–908.
   PubMedGoogle Scholar
• J Keller, and P Layer. (2005). Human pancreatic exocrine response to nutrients in health and disease. Gut 54 (Suppl 6):vi1–v28.
   PubMedGoogle Scholar
• J Keller, G Groger, L Cherian, B Gunther, and P Layer. (2001). Circadian coupling between pancreatic secretion and intestinal motility in humans. Am J Physiol Gastrointest Liver Phys 280 (2):G273–G278.
   PubMed Web of Science ®Google Scholar
• CW Leong, JM Newton, AW Basit, F Podczeck, JH Cummings, and SG Ring. (2002). The formation of colonic digestible films of amylose and ethylcellulose from aqueous dispersions at temperatures below 37°C. Eur J Pharm Biopharm 54 (3):291–297.
   PubMed Web of Science ®Google Scholar
• GT MacFarlane, and HN Englyst. (1986). Starch utilization by the human large intestinal microflora. J Appl Bacteriol 60 (3):195–201.
   PubMedGoogle Scholar
• M Mackay, J Phillips, and J Hastewell. (1997). Peptide drug delivery: Colonic and rectal absorption. Adv Drug Deliv Rev 28 (2):253–273.
   Web of Science ®Google Scholar
• JR Malagelada, VLW Go, and WHJ Summerskill. (1979). Different gastric, pancreatic, and biliary responses to solid–liquid or homogenized meals. Dig Dis Sci 24 (2):101–110.
   PubMed Web of Science ®Google Scholar
• EL McConnell, J Tutas, MAM Mohamed, D Banning, and AW Basit. (2007). Colonic drug delivery using amylose films: The role of aqueous ethylcellulose dispersions in controlling drug release. Cellulose 14 (1):25–34.
   Web of Science ®Google Scholar
• EL McConnell, AW Basit, and S Murdan. (2008a). Colonic antigen administration induces significantly higher humoral levels of colonic and vaginal IgA, and serum IgG compared to oral administration. Vaccine 26 (5):639–646.
   PubMed Web of Science ®Google Scholar
• EL McConnell, HM Fadda, and AW Basit. (2008b). Gut instincts: Explorations in intestinal physiology and drug delivery. Int J Pharm doi: 101016/jijpharm200805012
   PubMedGoogle Scholar
• EL McConnell, MD Short, and AW Basit. (2008c). An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man. J Control Release 130 (2):154–160.
   PubMed Web of Science ®Google Scholar
• EL McConnell, S Murdan, and AW Basit. (2008d). An investigation into the digestion of chitosan (noncrosslinked and crosslinked) by human colonic bacteria. J Pharm Sci 97 (9):3820–3829.
   PubMed Web of Science ®Google Scholar
• LJ Miller, JE Clain, JR Malagelada, and VLW Go. (1979). Control of human postprandial pancreatic exocrine secretion—function of the gastroduodenal region. Dig Dis Sci 24 (2):150–154.
   PubMed Web of Science ®Google Scholar
• C Owyang, DS Louie, and D Tatum. (1986). Feedback-regulation of pancreatic-enzyme secretion—suppression of cholecystokinin release by trypsin. J Clin Invest 77 (6):2042–2047.
   PubMed Web of Science ®Google Scholar
• F Podczeck, JM Newton, and KH Yuen. (1995). The description of the gastrointestinal transit of pellets assessed by gamma scintigraphy using statistical moments. Pharm Res 12 (3):376–379.
   PubMed Web of Science ®Google Scholar
• M Rajilic-Stojanovic, H Smidt, and WM de Vos. (2007). Diversity of the human gastrointestinal tract microbiota revisited. Environ Microbiol 9 (9):2125–2136.
   PubMed Web of Science ®Google Scholar
• GL Simon, and SL Gorbach. (1984). Intestinal flora in health and disease. Gastroenterology 86 (1):174–193.
   PubMed Web of Science ®Google Scholar
• T Sousa, R Paterson, V Moore, A Carlsson, B Abrahamsson, and AW Basit. (2008). The gastrointestinal microbiota as a site for the biotransformation of drugs. Int J Pharm doi: 101016/jijpharm200807009
   Google Scholar
• AH Staib, D Loew, S Harder, EH Graul, and R Pfab. (1986). Measurement of theophylline absorption from different regions of the gastro-intestinal tract using a remote controlled drug delivery device. Eur J Clin Pharmacol 30 (6):691–697.
   PubMed Web of Science ®Google Scholar
• PWL Thimister, WPM Hopman, A Loualidi, G Rosenbusch, HL Willems, FJM Trijbels, and JBMJ Jansen. (1997a). Cholestyramine influences meal-stimulated pancreaticobiliary function and plasma cholecystokinin independent of gastric emptying and food digestion. Scan J Gastroenterol 32 (8):778–784.
   PubMed Web of Science ®Google Scholar
• PWL Thimister, WPM Hopman, RFC vanRoermund, HL Willems, G Rosenbusch, R Woestenborghs, and JBMJ Jansen. (1997b). Inhibition of pancreaticobiliary secretion by loperamide in humans. Hepatology 26 (2):256–261.
   PubMed Web of Science ®Google Scholar
• M Tubic-Grozdanis, J Hilfinger, G Amidon, J Kim, P Kijek, P Staubach, and P Langguth. (2008). Pharmacokinetics of the CYP 3A substrate simvastatin following administration of delayed versus immediate release oral dosage forms. Pharm Res 25 (7):1591–1600.
   PubMed Web of Science ®Google Scholar
• PJ Wilson, and AW Basit. (2005). Exploiting gastrointestinal bacteria to target drugs to the colon: An in vitro study using amylose coated tablets. Int J Pharm 300 (1–2):89–94.
   PubMedGoogle Scholar
• O Wisen, PM Hellstrom, and C Johansson. (1993). Meal energy density as a determinant of postprandial gastrointestinal adaptation in man. Scand J Gastroenterol 28 (8):737–743.
   PubMed Web of Science ®Google Scholar
• KH Yuen, AA Deshmukh, and JM Newton. (1993a). Development and in vitro evaluation of a multiparticulate sustained-release theophylline formulation. Drug Dev Ind Pharm 19 (8):855–874.
   Web of Science ®Google Scholar
• KH Yuen, AA Deshmukh, JM Newton, M Short, and R Melchor. (1993b). Gastrointestinal transit and absorption of theophylline from a multiparticulate controlled-release formulation. Int J Pharm 97 (1–3):61–77.
   Web of Science ®Google Scholar